3 In January 2026, the FDA published the largest review to date, analysing 91 placebo-controlled GLP-1 trials covering 107,910 patients alongside a real-world cohort study of 2.2 million patients
Once reconstituted, the stability is the same regardless of whether you mixed a 10 mg vial or a 60 mg vial
Eating Your Way Through the World with Type 1 Diabetes: Real Talk from Someone Who's Done It Traveling with Type 1 diabetes doesn't mean playing it safe at every meal
A lipid panel provides cardiovascular risk context that often improves meaningfully during the course of therapy
Manufactured by Novo Nordisk, semaglutide is a GLP-1 receptor agonist (glucagon-like peptide-1) that is used to improve blood sugar control (Ozempic and Rybelsus) in individuals with type 2 diabetes mellitus and to support chronic weight management (Wegovy) in individuals who are obese or overweight
For the subgroup analysis of the time to the first occurrence of the main 5-component composite endpoint, the pre-specified Cox regression model also included an interaction between treatment group and the subgroup of interest, with the interaction P values evaluated using a score test